is saxenda a glp 1 drug Regulator keeps close eye on GLP-1 weight loss drugs' possible link to suicidal thoughts < Pharma < Article Saxenda© – A New Treatment
Description
In animal studies, GLP-1 agonists were excreted in breast milk
Inflammation is the primary pathological mechanism underlying CAD, since is involved in atherosclerotic plaque formation
GLP-1 receptor agonists: beyond their pancreatic effects
Furthermore, the review showed that both semaglutide and tirzepatide significantly increased the risk of flatulence
Cardiovascular and Metabolic Benefits GLP-1 agonists reduce cardiovascular disease (CVD) risk factors, including hypertension, dyslipidemia, and systemic inflammation
P = 0.017) compared to nonfatal myocardial infarction (HR 0.96
